Abstract
The development of 3D image-based treatment planning in brachytherapy has significantly improved the 3D assessment of dose-volume relations. Dose distribution can now be evaluated in different volumes such as the GTV, CTV, PTV and most relevant organs at risk (OARs). In general, in brachytherapy, target and organs at risk (OARs) volumes are similar to that in external beam radiotherapy, while prescriptions are based on International Commission on Radiation Units and Measurements (ICRU) Reports 38 and 58. The gross tumour volume (GTV) is the gross palpable or visible/demonstrable extent and location of the malignant growth. The GTV may appear to be different in size and shape, depending on the examination technique used for evaluation, and therefore, the radiation oncologist should, in each case, indicate which method has been used for delineation of the GTV. The definitions of GTV and CTV in brachytherapy are identical to the definitions given for external beam radiotherapy in ICRU Reports 50 and 62. The CTV (according to GEC-ESTRO) is also divided based on clinical examination and MRI study into high-risk CTV (HR CTV) which is at major risk of recurrence and intermediate-risk CTV (IR CTV) which has risk of recurrence in areas that initially had macroscopic extent of disease with residual microscopic disease at time of BT. During evaluation of plans, V90%, V150% and V200%, i.e. volumes of PTV receiving 90%, 150% and 200% of prescribed dose, respectively, are a clinically more relevant parameter. V200% in the target volume should ideally be located inside the applicator and V150% as far as possible at the tissue-applicator interface. The PTV should be covered by 85–90% isodose but not less than 80% isodose.
References
ICRU, International Commission on Radiation Units and Measurements. Dose and volume specification for reporting intracavitary therapy in gynecology. ICRU Report 38. Bethesda: ICRU; 1985.
ICRU, International Commission on Radiation Units and Measurements. Dose and volume specification for reporting interstitial therapy. ICRU Report 58. Bethesda: ICRU; 1997.
ICRU, International Commission on Radiation Units and Measurements. Prescribing, recording and reporting photon beam therapy. ICRU Report 50. Bethesda: ICRU; 1993.
ICRU, International Commission on Radiation Units and Measurements. Prescribing, recording and reporting photon beam therapy (Supplement to ICRU report 50) ICRU Report 62. Bethesda: ICRU; 1999.
Haie-Méder C, Potter R, Van Limbergen E, et al. Recommendations of gynecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D imaged based 3D planning in cervical cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005;74(3):235–45.
Mazeron JJ, Ardiet JM, Haie-Méder C, et al. GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas. Radiother Oncol. 2009;91:150–6.
Rustgi SN, Cumberlin RL. An afterloading 192-Ir surface mould. Med Dosim. 1993;18:39–42.
Takeda M, Shibuya H, Inoue T. The efficacy of gold-198 grain mould therapy for mucosal carcinomas of the oral cavity. Acta Oncol. 1996;35:463–7.
Chalian VA, Drane JB, Standish SM. Maxillofacial prosthetics. Baltimore: The William and Wilkins; 1972. p. 181–3.
Tod M, Meredith WJ. Treatment of cancer of the cervix uteri: a revised Manchester method. Br J Radiol. 1953;26:252–7.
Vishwanathan AN, Thomadsen B. American Brachytherapy Society consensus guidelines for locally advanced carcinoma cervix. Part I: General principles. Brachytherapy. 2012;11:33–46.
Chassagne D, Horiot JC. Proposal for common definitions of reference points in gynecological brachytherapy [French]. J Radiol Electrol Med Nucl. 1977;58(5):371–3.
Potish RA, Gerbi BJ. Role of point A in the era of computed dosimetry. Radiology. 1986;158:827–31.
Pötter R, Van Limbergen E, Gerstner N, Wambersie A. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy. Radiother Oncol. 2001;58:1–4.
Fletcher GH. Squamous cell carcinoma of the uterine cervix. In:Textbook of radiotherapy. Philadelphia: Lea & Febiger; 1980. p. 720–89.
Vishwanathan AN, Dimopoulos J, Kirisits C, et al. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys. 2007;68:491–8.
Pötter R, Van Limbergen E, Dries W, et al. Recommendations of the EVA GEC ESTRO Working Group: prescribing, recording and reporting in endovascular brachytherapy. Quality assurance, equipment, personnel and education. Radiother Oncol. 2001;59:339–60.
Kurhanewicz J, Vigneron B, Nelson S. Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. Neoplasia. 2000;2:166.
Lahanas M, Baltas D, Zambouglou N. Anatomy-based three-dimensional dose optimization in brachytherapy using multiple objective genetic algorithm. Med Phys. 1999;26:9.
Hsu I-C, Lessard E, Weinberg V, et al. Comparison of inverse planning and geometrical optimization for prostate high dose rate brachytherapy. Presented at the 23rd American Brachytherapy Society Meeting, Orlando, 24 May 2002.
Pouliot J, Charra-Brunaud C, Kim YB, et al. Inverse planning for HDR brachytherapy: Clinical implementation. Presented at the 23rd American Brachytherapy Society Meeting, Orlando, 24 May 2002.
Lessard E, Pouliot J. Anatomy-based dose optimization for HDR-brachytherapy of the prostate using fast simulated annealing algorithm. Med Phys. 2001;28:773.
Pouliot J, Tremblay D, Roy J, Filice S. Optimization of permanent 125I prostate implants using fast simulated annealing. Int J Radiat Oncol Biol Phys. 1996;36:711.
Kneschaurek P, Schiessl W, Wehrmann R. Volume-based dose optimization in brachytherapy. Int J Radiat Oncol Biol Phys. 1999;45:811.
Morton G, Sankreacha R, Halina P, et al. A comparison of anatomy-based inverse planning with simulated annealing and graphical optimization for high-dose-rate prostate brachytherapy. Brachytherapy. 2008;7:12–6.
Jacob D, Raben A, Sarkar A, et al. Anatomy-based inverse planning simulated annealing optimization in high-dose-rate prostate brachytherapy: significant dosimetric advantage over other optimization techniques. Int J Radiat Oncol Biol Phys. 2008;72(3):820–7.
Fisch BM, Pickett B, Weinberg V, et al. Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer. J Urol. 2001;57:955–9.
Georg P, Lang S, Dimopoulos JC, et al. Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys. 2011;79:356–62.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Mukherji, A. (2018). Brachytherapy Planning and Evaluation. In: Basics of Planning and Management of Patients during Radiation Therapy. Springer, Singapore. https://doi.org/10.1007/978-981-10-6659-7_14
Download citation
DOI: https://doi.org/10.1007/978-981-10-6659-7_14
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-6658-0
Online ISBN: 978-981-10-6659-7
eBook Packages: MedicineMedicine (R0)